Effect of adipose tissue-derived stem cell injection in a rat model of urethral fibrosis.

INTRODUCTION We sought to evaluate the therapeutic effect of adi-pose tissue-derived stem cells (ADSCs) in a rat model of urethral fibrosis. METHODS Eighteen (18) male Sprague-Dawley rats (300‒350 g) were divided into three groups: (1) sham (saline injection); (2) urethral fibrosis group (10 μg transforming growth factor beta 1 (TGF-β1) injection); and (3) ADSCs group (10 μg TGF-β1 injection plus 2 × 105 ADSCs). Rat ADSCs were harvested from rat inguinal fat pads. All study animals were euthanized at two weeks after urethral injection. Following euthanasia, rat urethral tissue was harvested for histologic evaluation. Type I and III collagen levels were quantitated by Western blot analysis. RESULTS TGF-β1 injection induced significant urethral fibrosis and increased collagen type I and III expression (p<0.05). Significant decrease in submucosal fibrosis and collagen type I and III expression were noted in the ADSCs group compared with the urethral fibrosis group (p<0.05). TGF-β1 induced fibrotic changes were ameliorated by injection of ADSCs. CONCLUSIONS Local injection of ADSCs in a rat model of urethral fibrosis significantly decreased collagen type I and III. These findings suggest that ADSC injection may prevent scar formation and potentially serve as an adjunct treatment to increase the success rate of primary treatment for urethral stricture disease. Further animal and clinical studies are needed to confirm these results.

[1]  W. Hellstrom,et al.  Transforming Growth Factor-β1 Induced Urethral Fibrosis in a Rat Model. , 2015, The Journal of urology.

[2]  Thomas G. Smith,et al.  Intralesional injection of mitomycin C at transurethral incision of bladder neck contracture may offer limited benefit: TURNS Study Group. , 2015, The Journal of urology.

[3]  K. Rourke,et al.  Stricture length and etiology as preoperative independent predictors of recurrence after urethroplasty: A multivariate analysis of 604 urethroplasties. , 2014, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[4]  W. Hellstrom,et al.  Adipose tissue–derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease , 2014, Andrology.

[5]  F. Montorsi,et al.  Intratunical injection of human adipose tissue-derived stem cells prevents fibrosis and is associated with improved erectile function in a rat model of Peyronie's disease. , 2013, European urology.

[6]  R. Pickard,et al.  Long-term effect of urethral dilatation and internal urethrotomy for urethral strictures , 2012, Current opinion in urology.

[7]  A. Parini,et al.  Intraparenchymal Injection of Bone Marrow Mesenchymal Stem Cells Reduces Kidney Fibrosis after Ischemia-Reperfusion in Cyclosporine-Immunosuppressed Rats , 2012, Cell transplantation.

[8]  De-sheng Wang,et al.  Intravenous injection of mesenchymal stem cells is effective in treating liver fibrosis. , 2012, World journal of gastroenterology.

[9]  Qiang Fu,et al.  Tissue engineering and stem cell application of urethroplasty: from bench to bedside. , 2012, Urology.

[10]  L. Ignarro,et al.  Adipose tissue-derived stem cell-seeded small intestinal submucosa for tunica albuginea grafting and reconstruction , 2012, Proceedings of the National Academy of Sciences.

[11]  A. Boulares,et al.  Cordycepin Blocks Lung Injury-Associated Inflammation and Promotes BRCA1-Deficient Breast Cancer Cell Killing by Effectively Inhibiting PARP , 2011, Molecular medicine.

[12]  Yan Liu,et al.  Human urine-derived stem cells seeded in a modified 3D porous small intestinal submucosa scaffold for urethral tissue engineering. , 2011, Biomaterials.

[13]  James J. Yoo,et al.  Halofuginone-coated urethral catheters prevent periurethral spongiofibrosis in a rat model of urethral injury. , 2011, Journal of endourology.

[14]  A. Harraz,et al.  Tissue engineering and stem cells: Basic principles and applications in urology , 2010, International journal of urology : official journal of the Japanese Urological Association.

[15]  A. Donnenberg,et al.  Localization of CD44 and CD90 positive cells to the invasive front of breast tumors , 2010, Cytometry. Part B, Clinical cytometry.

[16]  R. Santucci,et al.  The morbidity of urethral stricture disease among male Medicare beneficiaries , 2010, BMC urology.

[17]  B. Breyer,et al.  Multivariate analysis of risk factors for long-term urethroplasty outcome. , 2010, The Journal of urology.

[18]  Jia Lishan Repairing urethral defect with adipose-derived mesenchymal stem cells seeded on a porous silk fibroin scaffold in rabbits , 2010 .

[19]  J. Meeks,et al.  Stricture recurrence after urethroplasty: a systematic review. , 2009, The Journal of urology.

[20]  N. Lumen,et al.  Etiology of urethral stricture disease in the 21st century. , 2009, The Journal of urology.

[21]  A. Trounson,et al.  Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury. , 2009, The American journal of pathology.

[22]  Bindiya Patel,et al.  Adipose-derived stem cells: isolation, expansion and differentiation. , 2008, Methods.

[23]  A. Ayyıldız,et al.  Re: Hamid Mazdak, Iraj Meshki and Fatemeh Ghassami. Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. Eur Urol 2007;51:1089-92. , 2007, European urology.

[24]  F. Sampaio,et al.  A morphometric analysis of bulbar urethral strictures , 2007, BJU international.

[25]  R. Santucci,et al.  Male urethral stricture disease. , 2007, The Journal of urology.

[26]  H. Mazdak,et al.  Effect of mitomycin C on anterior urethral stricture recurrence after internal urethrotomy. , 2007, European urology.

[27]  A. Atala,et al.  Prospects for Engineering the Urinary Tract , 2004, Nephron Experimental Nephrology.

[28]  F. Sampaio,et al.  Extracellular matrix changes in urethral stricture disease. , 2002, The Journal of urology.

[29]  H. Blau,et al.  The Evolving Concept of a Stem Cell Entity or Function? , 2001, Cell.

[30]  O. Gofrit,et al.  The effect of halofuginone, an inhibitor of collagen type i synthesis, on urethral stricture formation: in vivo and in vitro study in a rat model. , 2000, The Journal of urology.

[31]  A. Melman,et al.  Collagen alterations in the corpus cavernosum of men with sexual dysfunction. , 1992, The Journal of urology.

[32]  George L. Wright,et al.  Isolation and characterization of collagen in Peyronie's disease. , 1989, The Journal of urology.

[33]  L. F. Greene,et al.  Treatment of urethral strictures by intralesional infections of steroids, internal urethrotomy and intubation with silastic catheter. , 1974, The Journal of urology.